$PPHM Company News

New Post Public Reply Private Reply Replies (0) Message Board

Sep 24, 2014 at 12:31 PM

$PPHM Company News

Apollo slammed on education department review
6:09 p.m. July 14, 2014
- Tom Bemis

Peregrine plunges on test data

4:17 p.m. June 27, 2013
- Russ Britt

Small-cap makes a splash with FDA nod for cancer drug

3:16 p.m. May 20, 2013
- Russ Britt

Peregrine drug shows promise in pancreatic cancer
1:17 p.m. Feb. 13, 2013
- MarketWatch.com

In focus: Bullish, but overbought
8:06 p.m. Jan. 9, 2013
- Lawrence G. McMillan

Hedge funds are bullish on these stocks
11:57 a.m. Dec. 5, 2012
- Insider Monkey

Peregrine, FDA agree on brain-cancer drug study
11:56 a.m. Dec. 5, 2012
- MarketWatch.com

Drug trial contractors improve efficiency
10:24 a.m. Nov. 16, 2012
- MarketWatch.com

Monday’s biggest gaining and declining stocks
6:42 p.m. Sept. 25, 2012
- Greg Morcroft

Tuesday’s biggest gaining and declining stocks
5:09 p.m. Sept. 25, 2012
- Greg Morcroft

Peregrine Pharma down 86% after test data review
8:27 a.m. Sept. 24, 2012
- Steve Gelsi

Peregrine Pharma down 86% in premarket
8:18 a.m. Sept. 24, 2012
- Steve Gelsi

Peregrine reviewing Bavituximab results
7:42 a.m. Sept. 24, 2012
- Greg Morcroft

Some previous Bavituximab data not valid

eregrine
7:42 a.m. Sept. 24, 2012
- Greg Morcroft

Monday’s biggest gaining and declining stocks
2:42 p.m. Sept. 10, 2012
- MarketWatch

Regions Financial, Williams-Sonoma hit 52-week highs; Intel, Cisco active

11:11 a.m. Sept. 10, 2012
- blogs.marketwatch.com

Stocks to watch Monday: AIG, Michael Kors, Sears
6:41 a.m. Sept. 10, 2012
- MarketWatch

Peregrine rallies on bavituximab lung-cancer data
1:29 p.m. Sept. 7, 2012
- MarketWatch.com

Monday’s biggest gaining & declining stocks
2:53 p.m. Aug. 27, 2012
- MarketWatch

Peregrine Pharma slides 12% after negative report
2:21 p.m. Aug. 27, 2012
- Val Brickates Kennedy

Peregrine Pharmaceuticals' Q1 Loss Wider than Expected - Analyst Blog

9:00 a.m. Sept. 10, 2014
- Zacks.com

Peregrine Pharmaceuticals' (PPHM) CEO Steven King on Q1 2015 Results - Earnings Call Transcript

7:53 p.m. Sept. 9, 2014
- Seeking Alpha

10-Q: PEREGRINE PHARMACEUTICALS INC
4:29 p.m. Sept. 9, 2014
- Edgar Online - (EDG = 10Q, 10K)

Peregrine Pharmaceuticals (PPHM) Q1 2015 Results - Earnings Call Webcast

4:25 p.m. Sept. 9, 2014
- Seeking Alpha

Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade

3:12 p.m. Aug. 27, 2014
- Seeking Alpha

Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies

10:43 a.m. Aug. 12, 2014
- Seeking Alpha

Peregrine Pharmaceuticals' Q4 Loss Narrower than Expected - Analyst Blog

11:00 a.m. July 15, 2014
- Zacks.com

Peregrine Pharmaceuticals' (PPHM) CEO Steven King on Q4 2014 Results - Earnings Call Transcript

10:21 p.m. July 14, 2014
- Seeking Alpha

10-K: PEREGRINE PHARMACEUTICALS INC
5:00 p.m. July 14, 2014
- Edgar Online - (EDG = 10Q, 10K)

More on Peregrine fiscal Q4 and fiscal year results

4:26 p.m. July 14, 2014
- Seeking Alpha

Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events

9:30 a.m. July 14, 2014
- TheStreet.com

First Week Of January 2015 Options Trading For Peregrine Pharmaceuticals (PPHM)

11:09 a.m. May 20, 2014
- TheStreet.com

Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack

6:00 a.m. May 9, 2014
- TheStreet.com

Peregrine wins law suit

9:24 a.m. May 5, 2014
- Seeking Alpha

Medivation Signs Deal with OncoFusion Therapeutics - Analyst Blog

6:24 p.m. April 24, 2014
- Zacks.com

Interesting PPHM Call Options For June 21st

11:02 a.m. April 23, 2014
- TheStreet.com

Peregrine's Bavituximab has high success rate in animal testing

9:47 a.m. April 7, 2014
- Seeking Alpha

Peregrine Pharmaceuticals (PPHM) Shares March Higher, Can It Continue? - Tale of the Tape

8:39 a.m. March 18, 2014
- Zacks.com

Cel-Sci's Multikine - Potential 21st Century Superdrug

5:41 p.m. March 13, 2014
- Seeking Alpha

Peregrine antibodies boost anti-tumor activity in animal studies

9:47 a.m. March 11, 2014
- Seeking Alpha

Peregrine Pharmaceuticals Reports First Quarter Fiscal Year 2015
Financial Results and Recent Developments
4:01 p.m. Sept. 9, 2014
- Marketwire

Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E
Convertible Preferred Stock
4:00 p.m. Sept. 8, 2014
- Marketwire

Peregrine Pharmaceuticals to Report First Quarter Fiscal Year 2015
Financial Results After Market Close on September 9, 2014
4:01 p.m. Sept. 2, 2014
- Marketwire

Preclinical Data Presented at Annual Immunotherapies and Vaccine
Summit Show That the Combination of Peregrine Pharmaceuticals'
PS-Targeting Antibodies and Anti-PD-1 Antibodies Significantly Reduce
Breast Cancer Progression
8:03 a.m. Aug. 11, 2014
- Marketwire

Small companies lead the I-O class of Cancer Therapies
8:03 a.m. Aug. 8, 2014
- ACCESSWIRE

Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma
9:00 a.m. Aug. 1, 2014
- PR Newswire - PRF

Peregrine Pharmaceuticals Reports Fourth Quarter and Year-End Fiscal
Year 2014 Financial Results and Recent Developments
4:01 p.m. July 14, 2014
- Marketwire

Peregrine Pharmaceuticals to Report Fourth Quarter and Year-End
Fiscal 2014 Financial Results After Market on July 14, 2014
4:00 p.m. July 7, 2014
- Marketwire

Technical Scrutiny on Biotech Stocks -- Research on Insmed, Peregrine Pharma, CytRx, and Celldex Therapeutics
6:40 a.m. June 30, 2014
- PR Newswire - PRF

Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E
Convertible Preferred Stock
4:00 p.m. June 10, 2014
- Marketwire

Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma
8:30 a.m. May 30, 2014
- PR Newswire - PRF

Biotech Stocks Scanner -- Research on PDL BioPharma, Cytokinetics, Vical, and Peregrine Pharma
12:41 p.m. May 6, 2014
- PR Newswire - PRF

Peregrine Pharmaceuticals Announces Initiation of an
Investigator-Sponsored Trial Combining Its Immunotherapy Bavituximab
and Ipilimumab (Yervoy(R)) in Advanced Melanoma
7:31 a.m. April 23, 2014
- Marketwire

Healthcare Companies Report Results, Patents, and Stock Movements - Analyst Notes on Puma Biotechnology, Alnylam, INSYS Therapeutics, Peregrine Pharmaceuticals, and VIVUS
12:28 p.m. April 10, 2014
- PR Newswire - PRF

Data Presented at AACR Support Potential of Peregrine's PS-Targeting
Immunotherapy Bavituximab to Enhance Anti-Tumor and
Immune-Stimulating Effects of Anti-CTLA-4 and Anti-PD-1 Treatments in
Models of Melanoma and Colon Cancer
11:01 a.m. April 9, 2014
- Marketwire

Morning Review on Top Gainers -- Research on Peregrine Pharma, Agios Pharma, Idenix Pharma, and Lexicon Pharma
1:15 p.m. April 8, 2014
- PR Newswire - PRF

Data Presented at AACR Support Potential of Combining Peregrine's
PS-Targeting Immunotherapy Agent Bavituximab With Irradiation in Lung
Cancer
8:04 a.m. April 7, 2014
- Marketwire

Peregrine Pharmaceuticals Announces Three Abstracts Accepted for
Presentation at AACR 2014 Annual Meeting
4:01 p.m. April 1, 2014
- Marketwire

Presentation at Annual Society of Surgical Oncology Meeting Updates
Progress in Investigator-Sponsored Phase i/ii Trial of Peregrine's
Bavituximab in Combination With Sorafenib in Liver Cancer
8:02 a.m. March 14, 2014
- Marketwire

Preclinical Data Presentations at Keystone Symposia Highlight Broad
Immunotherapy Potential of Peregrine Pharmaceuticals' PS-Targeting
Antibodies
8:02 a.m. March 13, 2014
- Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Naviu's AI Travel Guide: Revolutionizing Japan Tours

A New Era of Touring Japan: Meet Naviu Alright, travelers, strap in—Naviu is about to flip your trip to Japan upside down. Launching November 1st, 2026, this AI-powered augmented reality travel companion is trying to make exploring Japan easier than ever. Behind this innovative gem is TANGLE Inc., working with technology so cutting-edge, it's practically slicing through...

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Langford Chosen for Navy Mutual's 2026 Bolles Award

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...

SKYWORTH Solar's Solavita: Energizing Global Microgrids

Aiming for Global Reach with Solavita Usually, when a company flings a new brand into the arena, you're looking at a whole bunch of promises and probably a fat folder of paperwork you don't want to read. But when SKYWORTH Solar dishes out Solavita as its new ace in the smart microgrid game, you reckon there's a bit of serious starch in the collar. Harnessing Worldwide...

HanAll F&B Pioneers New Path for Domestic Rice Noodles

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

ModelBest & OpenBMB Unveil Open-Source OCR Models

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Yangtze River Culture Festival Spotlights Integration, Tradition

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...

SAMILBIO Gambles on 'Chaeyun' Launch With November Events

Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...

Roof Flashing Insights with Expert Jeremiah Lightsey

Why Flashing Is the Backbone of a Leak-Free Roof Ever wonder why some roofs just seem to withstand the wrath of Mother Nature better? The answer, my friends, often boils down to a little unsung hero: roof flashing. Our roof parts aren't exactly playing an even game; you've got chimneys, walls, skylights, just asking for trouble. That's where flashing steps in like an...

Mastering Progressive Overload: Break Workout Plateaus

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...